» Articles » PMID: 24812208

The Cellular and Molecular Origin of Tumor-associated Macrophages

Overview
Journal Science
Specialty Science
Date 2014 May 10
PMID 24812208
Citations 722
Authors
Affiliations
Soon will be listed here.
Abstract

Long recognized as an evolutionarily ancient cell type involved in tissue homeostasis and immune defense against pathogens, macrophages are being rediscovered as regulators of several diseases, including cancer. Here we show that in mice, mammary tumor growth induces the accumulation of tumor-associated macrophages (TAMs) that are phenotypically and functionally distinct from mammary tissue macrophages (MTMs). TAMs express the adhesion molecule Vcam1 and proliferate upon their differentiation from inflammatory monocytes, but do not exhibit an "alternatively activated" phenotype. TAM terminal differentiation depends on the transcriptional regulator of Notch signaling, RBPJ; and TAM, but not MTM, depletion restores tumor-infiltrating cytotoxic T cell responses and suppresses tumor growth. These findings reveal the ontogeny of TAMs and a discrete tumor-elicited inflammatory response, which may provide new opportunities for cancer immunotherapy.

Citing Articles

Are monocytes a preferable option to develop myeloid cell-based therapies for solid tumors?.

Bhatia D, Dolcetti R, Mazzieri R J Exp Clin Cancer Res. 2025; 44(1):98.

PMID: 40089746 DOI: 10.1186/s13046-025-03359-x.


Disulfidptosis related immune genes drive prognostic model development and tumor microenvironment characterization in bladder urothelial carcinoma.

Guo S, Lv G, Zhu H, Guo Y, Yin K, Yu H Sci Rep. 2025; 15(1):8130.

PMID: 40057601 PMC: 11890603. DOI: 10.1038/s41598-025-92297-x.


Advanced Nanoprobe Strategies for Imaging Macrophage Polarization in Cancer Immunology.

Zhang J, Tang K, Yang Y, Yang D, Fan W Research (Wash D C). 2025; 8:0622.

PMID: 39990770 PMC: 11842672. DOI: 10.34133/research.0622.


Suppression of MCP-1, IFN-γ and IL-6 production of HNSCC by pembrolizumab added to docetaxel and cisplatin (TP) exceeding those of TP alone is linked to improved survival.

Wellhausen J, Rohl L, Berszin M, Krucken I, Zebralla V, Pirlich M Front Immunol. 2025; 15:1473897.

PMID: 39882242 PMC: 11774711. DOI: 10.3389/fimmu.2024.1473897.


Noninvasive in vivo imaging of macrophages: understanding tumor microenvironments and delivery of therapeutics.

Gangadaran P, Onkar A, Rajendran R, Goenka A, Oh J, Khan F Biomark Res. 2025; 13(1):20.

PMID: 39865337 PMC: 11770947. DOI: 10.1186/s40364-025-00735-9.


References
1.
Serbina N, Hohl T, Cherny M, Pamer E . Selective expansion of the monocytic lineage directed by bacterial infection. J Immunol. 2009; 183(3):1900-10. PMC: 2753883. DOI: 10.4049/jimmunol.0900612. View

2.
DeNardo D, Barreto J, Andreu P, Vasquez L, Tawfik D, Kolhatkar N . CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell. 2009; 16(2):91-102. PMC: 2778576. DOI: 10.1016/j.ccr.2009.06.018. View

3.
Yona S, Kim K, Wolf Y, Mildner A, Varol D, Breker M . Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity. 2013; 38(1):79-91. PMC: 3908543. DOI: 10.1016/j.immuni.2012.12.001. View

4.
Radtke F, MacDonald H, Tacchini-Cottier F . Regulation of innate and adaptive immunity by Notch. Nat Rev Immunol. 2013; 13(6):427-37. DOI: 10.1038/nri3445. View

5.
Wang H, Joyce J . Alternative activation of tumor-associated macrophages by IL-4: priming for protumoral functions. Cell Cycle. 2010; 9(24):4824-35. PMC: 3047808. DOI: 10.4161/cc.9.24.14322. View